Articles Referencing PTX
Pernix Reports Loss in 1Q - Analyst Blog
5/13/2013, 3:16 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc's ( PTX ) first quarter
2013 adjusted loss (including stock-based compensation expense) of
6 cents per share, compared unfavorably to the Zacks... Read >>
Pernix Reports Loss in 4Q - Analyst Blog
3/21/2013, 2:33 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc ( PTX ) posted a loss of
2 cents per share in the fourth quarter of 2012 compared to
earnings of 15 cents per share in the year-ago quarter. ... Read >>
Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO
3/15/2013, 4:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 03/18/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. KiOR, Inc. ( KIOR )... Read >>
Pernix Completes Somaxon Buy - Analyst Blog
3/11/2013, 6:29 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc . ( PTX ) recently
completed its previously announced acquisition of Somaxon
Pharmaceuticals for $25 million. The acquisition was announced on
Dec 11,... Read >>
Actavis in Patent Challenge - Analyst Blog
3/11/2013, 5:12 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) announced that it
has amended its abbreviated new drug application (ANDA) for its
generic version of Novartis' ( NVS ) Exelon Patch
(rivastigmine transdermal... Read >>
Setback for Impax, Shares Plunge - Analyst Blog
3/6/2013, 5:55 pm from Zacks.com in Investing, Business, Stocks
Impax Laboratories, Inc. ( IPXL ) recently
announced that the US Food and Drug Administration (FDA) completed
its re-inspection of the company's manufacturing facility... Read >>
Good News for Pernix Therapeutics - Analyst Blog
3/5/2013, 4:55 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc ( PTX ) recently
announced that its subsidiary, Hawthorn Pharmaceuticals, Inc., has
received approval from the US Food and Drug Administration (FDA)
for... Read >>
Teva Enrolls First Patient in Study - Analyst Blog
2/12/2013, 5:10 pm from Zacks.com in Investing, Business, Stocks
Teva Pharmaceutical Industries Ltd. ( TEVA ) recently
announced that it has enrolled the first patient in the phase IV
MODERATO ( M ulticenter, Rand o
mized, D ouble-Blind,... Read >>
Perrigo in Expansion Mode - Analyst Blog
2/12/2013, 4:15 pm from Zacks.com in Investing, Business, Stocks
Perrigo Company ( PRGO ) recently
announced that it is set to acquire a UK-based privately held
pharmaceutical company, Rosemont Pharmaceuticals Ltd. and has
entered into a definitive... Read >>
Lannett Beats, Ups Guidance - Analyst Blog
2/11/2013, 2:24 pm from Zacks.com in Investing, Business, Stocks
Lannett Company, Inc. ( LCI ) reported second
quarter fiscal 2013 earnings of 10 cents per share, above the Zacks
Consensus Estimate of a loss of 3 cents and the year-ago earnings
of 2... Read >>
Oxtellar XR Launched by Supernus - Analyst Blog
2/5/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
Supernus Pharmaceuticals, Inc. ( SUPN ) recently
announced the launch of its antiepileptic drug, Oxtellar XR, in the
US. Oxtellar XR was approved by the US Food and Drug... Read >>
Teva Ends CureTech Collaboration - Analyst Blog
2/4/2013, 1:40 pm from Zacks.com in Investing, Business, Stocks
Teva Pharmaceutical Industries Ltd. ( TEVA ) recently
terminated its collaboration with CureTech Ltd. for the development
of CT-011. The companies had signed the collaboration agreements... Read >>
Actavis Provides 2013 Guidance - Analyst Blog
1/31/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ), formerly known
as Watson Pharmaceuticals, Inc., recently provided an update on its
2012 performance, 2013 outlook and prospects. The company said that it expects... Read >>
PTX Reduces Sales Force, CFO Quits - Analyst Blog
1/28/2013, 5:18 pm from Zacks.com in Investing, Business, Stocks
Pernix Therapeutics Holdings, Inc. ( PTX ) recently
announced the integration of Hawthorn Pharmaceutical's sales forces
with its own. Moreover, the company restructured the combined... Read >>
Generic Launch at Dr. Reddy's - Analyst Blog
1/28/2013, 4:30 pm from Zacks.com in Investing, Business, Stocks
Dr. Reddy's Laboratories Ltd. ( RDY ) recently
announced that it has launched its generic version of Merck
& Co., Inc. 's ( MRK ) Clarinex Reditabs
(desloratadine 2.5 mg and 5... Read >>